PerkinElmer, Inc.
PKI
Classement en actions
#1433
PerkinElmer, Inc. operates as a global enterprise delivering innovative... PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Prix de l'action
$120.30
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$15.17B
Changement (1 jour)
0.05%
Changement (1 an)
0.00%
Pays
US
Échange PerkinElmer, Inc. (PKI)
Catégorie
Healthcare
Ratio P/E pour PerkinElmer, Inc. (PKI)
Ratio P/E au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de PerkinElmer, Inc., le ratio P/E actuel (TTM) est de 0. À la fin de l’année 2026, le P/E de l’entreprise était de 0.
Historique du ratio P/E pour PerkinElmer, Inc. de 2001 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2025 | 46.69 | 1.08% |
| 2024 | 46.19 | -140.11% |
| 2023 | -115.15 | -470.51% |
| 2022 | 31.08 | 25.50% |
| 2021 | 24.76 | 12.67% |
| 2020 | 21.98 | -53.53% |
| 2019 | 47.29 | 30.03% |
| 2018 | 36.37 | -49.38% |
| 2017 | 71.84 | 194.05% |
| 2016 | 24.43 | -13.88% |
| 2015 | 28.37 | -8.94% |
| 2014 | 31.16 | 13.04% |
| 2013 | 27.56 | -47.74% |
| 2012 | 52.74 | -97.26% |
| 2011 | 1.93K | 24,378.39% |
| 2010 | 7.88 | -71.83% |
| 2009 | 27.96 | 119.39% |
| 2008 | 12.75 | -45.25% |
| 2007 | 23.28 | -2.02% |
| 2006 | 23.76 | -36.23% |
| 2005 | 37.26 | -1.29% |
| 2004 | 37.74 | -7.13% |
| 2003 | 40.64 | -116.22% |
| 2002 | -250.53 | -95.76% |
| 2001 | -5.91K | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 36.15 | - |
US
|
|
| 39.77 | - |
US
|
|
| -290.26 | - |
US
|
|
| - | - |
CN
|
|
| 34.18 | - |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.